When a sample is applied to a rapid antigen test, a precisely orchestrated molecular handshake produces a simple visible line in minutes. The colloidal gold lateral flow immunoassay works by combining gold nanoparticle‑conjugated detector antibodies with the viral target in the sample. These immune complexes migrate along a nitrocellulose membrane by capillary action until they are captured by a fixed line of capture antibodies, where the accumulated gold creates a red/purple band. A second control line confirms the test ran correctly. To build these kits, developers need high‑purity capture and detector antibodies, stable colloidal gold, pre‑treated membrane matrices, and optimised buffer formulations—each selected with the same rigour as the assay design itself.
The core mechanism is a sandwich immunoassay on a porous strip: antigen links a gold‑labelled antibody to a membrane‑bound capture antibody. However, transforming this principle into a reliable IVD kit demands a disciplined approach to raw material quality—matched antibody pairs, uniform gold conjugates, and consistent membrane flow are the true enablers of sensitivity, specificity, and shelf stability.
How the Assay Detects Viral Antigens
The Sandwich Format and Signal Generation
The assay is built on a double‑antibody sandwich format. Detector antibodies specific to the viral antigen are conjugated to colloidal gold nanoparticles (typically 15–40 nm in diameter). When the sample fluid solubilises these dried conjugates, any target antigen present is ‘sandwiched’ between the detector antibody and a separate capture antibody immobilised further downstream.
This binding event concentrates the gold particles at the Test (T) line. Because colloidal gold strongly absorbs and scatters light, the accumulation becomes a visible pink‑to‑purple band even without any enzymatic reaction. No sophisticated reader is required—the naked eye suffices.
The Role of Capillary Flow
A nitrocellulose membrane acts as the chromatographic platform. Its high‑protein‑binding surface and controlled pore structure drive uniform capillary wicking. The sample, mixed with a running buffer, first rehydrates the conjugate pad and then flows into the membrane. The rate of flow and the residence time over the capture line directly impact binding efficiency, which makes membrane pore size (often 0.45 µm) and surfactant treatments critical.
Control Line Validation
Downstream of the test line, a Control (C) line contains immobilised species‑specific antibodies (e.g., anti‑mouse IgG if the gold conjugate uses mouse monoclonal antibodies). This captures excess gold conjugate regardless of antigen presence. A clear C‑line confirms proper membrane wicking, conjugate activity, and correct sample volume, invalidating any result where it fails to appear.
Essential Raw Materials for Developing the Kit
High‑Affinity Antibody Pairs (Capture and Detector)
The entire assay hinges on two antibodies that recognise non‑competing epitopes on the same viral antigen. The detector antibody must retain high affinity after conjugation to gold, while the capture antibody must bind tightly when passively adsorbed onto the membrane. Monoclonal antibodies are strongly preferred because their single‑epitope specificity reduces cross‑reactivity and allows precise cutoff tuning. Matched pairs validated for sandwich reactivity in the intended sample matrix are non‑negotiable.
Colloidal Gold Nanoparticles and Conjugation
Colloidal gold is the visual engine. Consistent particle size (often 20–40 nm) ensures reproducible colour intensity and conjugate stability. The conjugation process—usually passive adsorption of antibodies at an optimised pH and ionic strength—requires gold sols with minimal aggregate content. Stable gold conjugates maintain their optical signal after drying on a conjugate pad and during re‑solubilisation, directly impacting lot‑to‑lot reproducibility.
Pre‑Treated Nitrocellulose Membranes and Porous Pads
The nitrocellulose membrane is the capture matrix. It must have high protein binding capacity, low background, and a pore size that balances speed and sensitivity. Manufacturers often supply pre‑treated sheets (e.g., with blocking agents or wetting surfactants) to ensure uniform fluid front. In addition to the membrane, the test strip requires:
- A sample pad to buffer and pre‑filter the specimen.
- A conjugate release pad pre‑loaded with dried gold conjugate.
- An absorbent pad at the distal end to pull fluid through the membrane. All must be compatible with the chosen buffers and not leach interfering substances.
Sample Dilution Buffers and Blocking Agents
Running buffers and sample diluents (often phosphate‑buffered saline with Tween‑20, PBST) solubilise dried reagents, maintain the proteins’ native conformation, and reduce non‑specific binding. Blocking agents like bovine serum albumin or casein further coat any remaining non‑specific binding sites on the membrane and pads, keeping the background clean and the test line sharp.
Cassette Housing and Assembly Components
While the biochemistry does the work, the plastic cassette protects the strip, guides sample application, and provides a window for reading. High‑quality cassettes ensure consistent pressure on the strip, preventing channeling or uneven flow. They also incorporate a sample port and often a buffer well, sealing the strip against humidity to extend shelf life.
Design Considerations for Reliable Performance
Selecting Antibody Clones for Sensitivity and Specificity
Not all antibodies perform equally when one is conjugated to gold and the other is adsorbed to a membrane. Clone screening must test both configurations in a full‑strip format. The goal is to find pairs that yield a low limit of detection (often low ng/mL in the specimen matrix) without cross‑reacting with related viruses. Testing against negative clinical samples and potential interferents is essential to prevent false positives.
Optimising Gold Conjugate for Signal and Stability
The optical density of the conjugate, the amount loaded onto the pad, and the drying conditions all influence signal strength. Larger gold particles (40 nm) can generate stronger visual signal but may migrate more slowly and show higher non‑specific binding. The conjugation pH and stabiliser (e.g., trehalose, sucrose) are tuned to preserve activity during storage at ambient temperatures—a key requirement for point‑of‑care tests.
Membrane Pore Size and Wick Properties
A smaller pore size (e.g., 0.2 µm) increases surface area and can improve sensitivity but slows the assay and risks incomplete clearing. A larger pore size (0.45–0.8 µm) speeds fluid flow but reduces capture time. Pre‑treated membranes with optimised capillary speed and wettability ensure that the antigen‑conjugate complex has sufficient time to bind without causing high background.
Sample Processing and Matrix Effects
Viral antigen tests often use nasopharyngeal swabs, saliva, or fluid samples. The specimen must be compatible with the buffer. For tissue or viscous samples, a pre‑extraction step (e.g., shaking with beads in buffer) is required. The buffer must lyse viruses if necessary, solubilise antigens, and mitigate matrix effects like pH extremes or mucus that can block flow or denature antibodies.
Understanding the Trade‑offs
Sensitivity vs. Specificity
Pushing for maximum sensitivity by increasing conjugate load or lengthening incubation can raise non‑specific binding and false positives. Conversely, stringent wash steps and high blocking can shift the cutoff so high that weak true positives are missed. Developers must define a clinical cutoff that balances these two and validates it with a robust sample panel.
Speed vs. Limit of Detection
A test that yields a result in 2 minutes may sacrifixe the lower limit of detection. Slower membrane migration allows more immune complex capture but exposes the strip to edge effects and drying artefacts. The typical read window of 5–10 minutes is a compromise: long enough for sufficient signal, short enough for point‑of‑care workflow.
Stability vs. Cost
Lyophilised or desiccated conjugates stabilised with expensive sugars and oxygen‑blocking packaging can maintain activity for years at room temperature. Simplifying the formulation reduces manufacturing cost but can shorten shelf life or require cold‑chain storage. Every raw material choice—from the gold sol’s purity to the adhesive on the backing card—affects both shelf stability and unit cost.
Making the Right Choice for Your Kit Development
The raw materials you choose must align with the test’s intended use, performance requirements, and budget. Use these goal‑based recommendations to guide your selection:
- If your primary focus is maximum analytical sensitivity: Invest in monoclonal antibody pairs verified to capture low analyte concentrations, use larger colloidal gold (40 nm) with high optical density, and select a small‑pore nitrocellulose membrane with extended reaction time. Pair this with a detergent‑free or low‑detergent running buffer to preserve weak interactions.
- If your primary focus is batch‑to‑batch reproducibility: Source IVD‑grade gold conjugates with tight size distribution and pre‑treated membranes from a single, validated lot. Standardise all buffer formulations and drying protocols, and run internal controls on every batch.
- If your primary focus is field usability and ambient‑temperature stability: Prefer trehalose‑stabilised conjugate pads, enclosed cassette with desiccant, and blocking agents that remain active without refrigeration. Validate stability under accelerated storage conditions (e.g., 45°C for 30 days).
- If your primary focus is broad pathogen coverage with reduced development time: Employ a pan‑antigen targeting strategy using antibodies against conserved viral epitopes. Combine with a modular cassette design that allows swapping capture lines without changing the rest of the strip, speeding up variant‑specific kit iterations.
Every component, from the first drop of buffer to the final readout, is a deliberate choice—master that interplay and you turn a strip of membrane into a trusted diagnostic tool.
Summary Table:
| Key Component / Raw Material | Primary Function in Assay | Critical Selection Criteria |
|---|---|---|
| Detector Antibodies | Conjugated to gold; binds target viral antigen in sample | High affinity, retains binding after gold conjugation |
| Capture Antibodies | Immobilized at Test Line; traps antigen-detector complexes | Non-competing epitope, strong membrane adsorption |
| Colloidal Gold (15–40 nm) | Provides visual pink/purple optical signal at Test/Control lines | Uniform particle size, minimal aggregation, high stability |
| Nitrocellulose Membrane | Drives capillary wicking and immobilizes capture proteins | Controlled pore size (e.g., 0.45 µm), low background noise |
| Running Buffers & Blockers | Solubilizes reagents and blocks non-specific binding sites | PBST, BSA, trehalose for signal clarity & shelf stability |
Accelerate Your Rapid Test Development with CamelBio
Developing high-sensitivity, reliable lateral flow immunoassays requires uncompromised raw material quality and precise formulation. CamelBio provides diagnostic manufacturers, labs, and research institutes with one-stop access to IVD raw materials, technical services, and consulting—covering every stage from concept to clinic.
From high-affinity matched antibody pairs and uniform colloidal gold to membrane selection and buffer optimization, we help you overcome development bottlenecks and bring trusted rapid tests to market faster.
Contact CamelBio Today to request raw material samples or consult with our IVD technical experts!